Autopsy report · NCT01483820

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Lack of enrollment”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 3 years before it stopped.
8 participants enrolled.
Results were posted on the registry 1 year 10 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: Giselle Sholler
Sponsor type: University, hospital or other
Conditions: Neuroblastoma; Medulloblastoma
Interventions: TPI 287
Participants: 8
Sites: 8
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.